Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study
基于 Ki67 状态的 II-III 期乳腺癌新辅助内分泌治疗(序贯帕博西尼联合化疗):一项开放标签的 II 期研究
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104672
Engebrethsen, Christina; Yndestad, Synnøve; Rasmussen, Mari E; Janssen, Emiel A M; Gilje, Bjørnar; Blix, Egil S; Espelid, Helge; Lundgren, Steinar; Geisler, Jürgen; Minsaas, Laura; Lillestøl, Reidun; Aase, Hildegunn S; Aas, Turid; Lønning, Per E; Eikesdal, Hans P; Knappskog, Stian